PATENT CLAIM ANALYSIS

Application Number: 15908218
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["424", "133100"]

Abstract:
Anti-CD122 and/or γc antibodies and fragments thereof are disclosed. Also disclosed are compositions comprising such antibodies and fragments, and uses and methods using the same.

Claim (Index 7):
The antibody or antigen binding fragment according to  claim 6 , provided in scFv-KiH-Fc or CrossMab format.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 88.0
- Lexical Diversity: 1.4
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15229336', '15750425', '15495048', '15521514', '15521685']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8315797318104786
- 35 USC 102 Novelty (BERT): 0.6717225407645858
- Combined Prediction Score: 0.8155940127058893
- Mean Citation Score: 671.658462
- Max Citation Score: 975.4457
- Similarity Product: 635.0548252525924

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test